The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
Abingdon, UK - AMSBIO has published a new 25-page Neuroscience catalogue that details its extensive range of specific tools and reagents to enable researchers stay at the forefront of their field.
Read the rest of entry »
Oxford, UK - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and Clostridium difficile infection, announces that company management will participate in three upcoming investor conferences taking place in New York City in February.
Oxford, UK - Chronos Therapeutics Ltd (Chronos), the private biotech company focused on ageing diseases, brain and nervous system disorders, is honoured to announce that Dr Huw Jones, CEO of Chronos, has been awarded Best CEO in the European Drug Discovery Industry by online and print magazine European CEO.
Cambridge, UK - Arecor's Prototype liquid glucagon product shows stability and commercial viability - Partnership with Innovate UK to accelerate pre-clinical asset towards proof-of-concept & first-in-human trials.
Oxford, UK & Marlborough, USA - Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced Richard Altieri, Chief Financial Officer, will present at the Leerink Partners 6th Annual Global Healthcare Conference on Thursday, February 16, 2017, at 10:00 a.m. EST at the Lotte New York Palace in New York City.
Oxford, UK – Summit Therapeutics plc, the drug discovery and development company advancing therapies for Duchenne muscular dystrophy and C. difficile infection (‘CDI’), today outlines its Phase 3 programme for its novel antibiotic, ridinilazole, following recent regulatory meetings with the US Food and Drug Administration (‘FDA’) and European Medicines Agency (‘EMA’).
Birmingham & London, UK - SRG has appointed Marianna Suckova as Director of Clinical, based in London. Marianna Suckova brings extensive knowledge of Drug Development along with a notable pedigree in sales activities, recruitment, change management and people leadership.
Birmingham & Newcastle, UK - Science, clinical and engineering recruiter SRG has expanded its Newcastle office with the addition of two new recruiters. Joining the team are Associate Consultants Richard McDermott and Luke Argent, who arrive in response to growing demand for specialist recruitment services in the North East.
Oxford, UK – Glide Technologies, the pharmaceutical development and device company focused on the needle-free administration of solid dose formulations, today announced the successful completion of a funding round totalling £3.2 million ($4.0 million). The fundraising was supported by a number of existing investors.
Abingdon, UK - OBN, the membership organisation supporting the UK’s innovative life sciences companies is pleased to announce today that Venner Shipley, a leading firm of European patent & trade mark attorneys and IP lawyers, has become OBN’s exclusive patent and trade mark attorney sponsor.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.
This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc. Just drop an email to us, email@example.com, and we will post.